Antineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsDoxorubicinCisplatinChemotherapy, AdjuvantCell Line, TumorDrug Resistance, NeoplasmDrug Screening Assays, AntitumorAntibiotics, AntineoplasticApoptosisXenograft Model Antitumor AssaysPaclitaxelNeoplasmsEtoposideCombined Modality TherapyDrug SynergismCyclophosphamideAntineoplastic Agents, PhytogenicBreast NeoplasmsTumor Cells, CulturedMice, NudeCell SurvivalAntineoplastic Agents, AlkylatingTreatment OutcomeAntimetabolites, AntineoplasticDrug Resistance, MultipleLung NeoplasmsVinblastineDose-Response Relationship, DrugP-GlycoproteinDeoxycytidineNeoplasm TransplantationMethotrexateCell ProliferationTaxoidsCamptothecinDrug Administration ScheduleBleomycinDaunorubicinCarboplatinNeoplasms, ExperimentalOrganoplatinum CompoundsFluorouracilNeoadjuvant TherapyDisease-Free SurvivalOvarian NeoplasmsDrug Delivery SystemsMitomycinGene Expression Regulation, NeoplasticSurvival AnalysisProto-Oncogene Proteins c-bcl-2Time FactorsAdenocarcinomaPrognosisTumor Suppressor Protein p53Inhibitory Concentration 50Neoplasm StagingColonic NeoplasmsCytarabineDacarbazineMice, Inbred BALB CSurvival RateCarmustineMice, SCIDMitoxantroneCell CycleNeoplasm MetastasisLiver NeoplasmsDrug ResistanceMelanoma, ExperimentalBrain NeoplasmsCaspasesDNA DamageMelphalanAntibodies, MonoclonalOsteosarcomaTransplantation, HeterologousCarcinoma, Non-Small-Cell LungImmunotherapyFlow CytometryRNA, Small InterferingNeoplasm ProteinsCell DivisionLeukemia P388Tumor BurdenBlotting, WesternMelanomaSignal TransductionNeoplasm Recurrence, LocalColorectal NeoplasmsIfosfamideApoptosis Regulatory ProteinsCaspase 3VincristineDrug CarriersAnthracyclinesCell DeathMultidrug Resistance-Associated ProteinsBone NeoplasmsPancreatic Neoplasms